Search

Search Constraints

You searched for: Author/Creator Bono, Stephanie de

Search Results

1. 185 Baricitinib-associated changes in type I interferon gene signature during a 24-week phase 2 clinical SLE trial. (April 2019)

2. 199 Baricitinib in patients with systemic lupus erythematosus: results from a phase 2, randomized, double-blind, placebo-controlled study. (April 2019)

3. O4 Baricitinib-induced changes in STAT-associated gene expression in systemic lupus erythematosus. (23rd March 2020)

4. Patient-reported outcomes from a phase 3 study of baricitinib versus placebo or adalimumab in rheumatoid arthritis: secondary analyses from the RA-BEAM study. Issue 11 (10th August 2017)

5. THU0212 BARICITINIB-ASSOCIATED CHANGES IN GLOBAL GENE EXPRESSION DURING A 24-WEEK PHASE 2 CLINICAL SLE TRIAL DESCRIBE A MECHANISM OF ACTION THROUGH INHIBITION OF JAK/STAT AND IFN RESPONSIVE GENE EXPRESSION. (June 2019)